Farms.com Home   News

Dairy Defines Sustainability, Land O'lake's Kappelman Says

Sustainability is shaping the U.S. dairy industry’s future, making it better equipped to make sure the world has the nutrition it needs, says Pete Kappelman, a longtime dairy farmer and Land O’Lakes’ Senior Vice President of Member and Government Relations.

“U.S. dairy farmers are deeply involved and concerned about the many communities that they touch. And that starts with producing a safe, nutritious, affordable food, but it also includes things like being good stewards of the land, for the good of the planet,” as well as being able to pass a farm down to future generations, said Kappelman in a Dairy Defined podcast released today. “In order to feed a growing population, we’ve got to work together across continents, across cultures and markets to make abundant nutritious food available so everyone can realize their full potential.”

Kappelman also discusses industrywide sustainability commitments and Land O’Lakes Venture 37, which delivers market insights and technical expertise to agricultural development projects worldwide.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.